Doctor Maria Bageta
GMC Number:
Consultant Dermatologist
Dr Maria Bageta is a Paediatrician and Paediatric Dermatologist who works as a Consultant at Great Ormond Street Hospital where she reviews patients with complex paediatric dermatology conditions, leads a transition clinic for patients with ichthyosis and runs laser therapy lists for children with birthmarks under general and local anaesthesia.
Dr Bageta has a clinical interest in all skin conditions but specialises in eczema, haemangiomas (strawberry birthmarks), undiagnosed rashes, moles, birthmarks, and acne.
Dr Bageta has a passion for research and has worked as the lead research fellow in Mission EB, a cell therapy trial for children with recessive dystrophic epidermolysis bullosa. She is involved in a large research portfolio in Dermatology at GOSH, has presented her work at many international meetings in Dermatology, acts as a peer reviewer and has published several articles as main author and co-author in peer reviewed journals.
She has been recognised as a Future Leader in Paediatric Dermatology by the European Society for Paediatric Dermatology (ESPD). She is also a Fellow of the Royal College of Paediatrics and Child Health (FRCPCH) and an active member of Dermatology Societies such as ESPD, BAD, BSPAD and ISPD.
Dr Maria Bageta is a Paediatrician and Paediatric Dermatologist who works as a Consultant at Great Ormond Street Hospital where she reviews patients with complex paediatric dermatology conditions, leads a transition clinic for patients with ichthyosis and runs laser therapy lists for children with birthmarks under general and local anaesthesia.
Dr Bageta has a clinical interest in all skin conditions but specialises in eczema, haemangiomas (strawberry birthmarks), undiagnosed rashes, moles, birthmarks, and acne.
Dr Bageta has a passion for research and has worked as the lead research fellow in Mission EB, a cell therapy trial for children with recessive dystrophic epidermolysis bullosa. She is involved in a large research portfolio in Dermatology at GOSH, has presented her work at many international meetings in Dermatology, acts as a peer reviewer and has published several articles as main author and co-author in peer reviewed journals.
She has been recognised as a Future Leader in Paediatric Dermatology by the European Society for Paediatric Dermatology (ESPD). She is also a Fellow of the Royal College of Paediatrics and Child Health (FRCPCH) and an active member of Dermatology Societies such as ESPD, BAD, BSPAD and ISPD.
Areas of Expertise
Publications
Latest Publication:
Publications (link to research gate https://www.researchgate.net/scientific-contributions/Maria-L-Bageta-2193785568 and Linkedin https://www.linkedin.com/in/maria-laura-bageta-b46964183/?locale=es)
- What’s your diagnosis? Eczema Coxsackium. Medicina Infantil Journal. 2019;XXVI(N°4):407-408. Bageta ML, Tellería RL, Bocián M, et al.
- Clinical and epidemiological characteristics of patients with congenital epidermolysis bullosa confirmed by molecular study. Retrospective study in a pediatric hospital. Dermatologia Argentina Journal. 2019;25(4):152-160. ISSN 1515-8411 Bageta ML, Cella E, Martínez MF, et al.
- Congenital linear lesions in a pediatric patient. Dermatologia Argentina Journal. 2020;26(1):45-46. ISSN 1515-8411 (print), ISSN 1669-1636 Bageta ML, Bujan MM, Centeno MDV, Cervini AB.
- The Natural History of Severe Recessive Dystrophic Epidermolysis Bullosa – 4 phases which may help determine different therapeutic approaches. J Dermatol Venereol. 2021;2(2):20-21. Bageta ML, Yerlett N, Mc Grath JA, et al.
Read more...
- Epidermolysis bullosa acquisita: a case series of three paediatric patients. Clin Exp Dermatol. 2022 Jul;47(7):1346-1349. doi: 10.1111/ced.15112. Epub 2022 Mar 22. PMID: 35080258. Bageta ML, Cella E, Cervini AB, et al.
- Establishing an appropriate level of vitamin D supplementation in pediatric patients with recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2022 Jul;47(7):1307-1313. doi: 10.1111/ced.15156. Epub 2022 May 25. PMID: 35245948. Yerlett N, Loizou A, Bageta M, et al.
- The impact of using a multistrain probiotic supplement on gastrointestinal function in children and adolescents with severe recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol. 2022 Nov;00:1-5. doi: 10.1093/ced/llac070. Yerlett N, Petrof G, Bageta M, et al.
- Bi-allelic TUFT1 variant cause a syndrome of wooly hair and skin fragility. Br J Dermatol. 2023 Jan 23;188(1):75-83. doi: 10.1093/bjd/ljac026. Jackson A, Moss C, Bageta ML, et al.
- Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa – A series of six pediatric patients. Published online July 26, 2023. doi:10.1111/pde.15406. PMID: 37496109. Bageta ML, Yerlett N, Rybak A, et al.
- Hypermobility in patients with epidermolysis bullosa—a retrospective observational study from a national referral center. JEADV Clin Pract. 2023; 1–5. https://doi.org/10.1002/jvc2.323. Bageta ML, Wood M, Petrof G, et al
- Lentiviral expression of wild-type LAMA3A restores cell adhesion in airway basal cells from children with epidermolysis bullosa. Mol Ther. Published online February 29, 2024. doi:10.1016/j.ymthe.2024.02.032 Lau CH, Rouhani MJ, Bageta ML, et al.
- Early use of nasogastric tubes may lead to serious oesophageal complications in patients with severe epidermolysis bullosa. Clin Exp Dermatol. 2024;49(10):1259-1260. doi:10.1093/ced/llae195. Bageta ML, Yerlett N, Rybak A, et al.
- Mesenchymal intravenous stromal cell infusions in children with Recessive Dystrophic Epidermolysis Bullosa: MissionEB protocol for a randomised, double-blinded, placebo controlled, two centre, cross-over trial with an internal phase 1 dose de-escalation phase and open label extension. BMJ Open. 2025;15(5):e089857. Published 2025 May 21. doi:10.1136/bmjopen-2024-089857. Bageta ML, Lopez-Balboa P, Dimairo M, et al.
- Management of oesophageal strictures in inherited epidermolysis bullosa: a clinical practice guideline. Br J Dermatol. 2025;193(3):394-404. doi:10.1093/bjd/ljaf191. El Hachem M, Caldaro T, Bageta ML, et al.
- Mesenchymal intravenous stromal cell infusions in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a randomised, double-blinded, placebo controlled, cross-over trial. EClinicalMedicine. 2025;88:103417. Published 2025 Aug 14. doi:10.1016/j.eclinm.2025.103417. Bageta ML, Lopez-Balboa P, Bursnall M, et al.
- Incontinentia pigmenti: clinical heterogeneity and the role of early dermatological recognition. Br J Dermatol. 2025 Dec 19;193(Suppl 3):ljaf465.005. doi: 10.1093/bjd/ljaf465.005. PMID: 41412996. King Stokes N, O’Neill C, Bageta M, et al.
- Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with Recessive Dystrophic Epidermolysis Bullosa (MissionEB): a qualitative sub study of a randomised, double-blind, placebo controlled, crossover, phase 3 trial. Orphanet J Rare Dis 21, 272 (2026).https://doi.org/10.1186/s13023-026-04350-1. Biggs, K., Ditta, S., Bageta, M.L. et al.
- Factors Impacting Laxative Use in Children and Adolescents With Epidermolysis Bullosa: Single Centre Retrospective Study. Journal of Paediatrics and Child Health (2026): 1–6, https://doi.org/10.1111/jpc.70497. I. Cotton, N. Yerlett, Bageta M, et al.
Skin Cancer Screening Specialists
Latest technology ensures better and faster results.
Our Consultant Dermatologists use high-resolution imaging for accurate, painless diagnosis—an alternative to physical biopsy. We offer moles mapping, dermoscopy, and digital dermoscopy with cutting-edge, non-invasive tools. By reducing unnecessary biopsies, we provide a stress-free, scar-free experience, saving time and money.